
What We're Reading: Opposition to State Public Options; EHRs and Healthcare Fraud; Apixaban Generics Approved
Hospital and advocacy group opposition to state public options could foretell trouble for national single-payer efforts; electronic health records (EHRs) present new opportunities for fraud; the FDA has approved the first generic versions of apixaban (Eliquis).
Hospital Opposition to State Healthcare Reform Foreshadows Challenges for Congress
Electronic Health Records Creating a “New Era” of Healthcare Fraud, Officials Say
As individual states increase their efforts to implement public options for residents, insurance companies and hospitals are leading the opposition. Come January, Colorado will vote on a public option which would be managed by private insurers, and could save consumers up to 15% on premiums, according to
FDA Approves First Generics of Apixaban
The FDA has approved 2 generic versions for apixaban (Eliquis), which is used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, marking the first generic approvals of a direct oral anticoagulant, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.